We are live on ! Find out more
TA

Tamarack Advisers Portfolio holdings

AUM $2.12M
1-Year Est. Return 58.09%
This Fund
S&P 500
This Quarter Est. Return
-2.76%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$317M
AUM Growth
-$36.3M
Cap. Flow
-$25M
Cap. Flow %
-7.9%
Top 10 Hldgs %
56.14%
Holding
64
New
13
Increased
14
Reduced
15
Closed
19

Top Buys

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$8.9M
2
CALY
Callaway Golf Company
CALY
+$8.67M
3
STE icon
Steris
STE
+$7.7M
4
HSIC icon
Henry Schein
HSIC
+$6.54M
5
THC icon
Tenet Healthcare
THC
+$5.32M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$12M
2
VTRS icon
Viatris
VTRS
+$11.7M
3
CVS icon
CVS Health
CVS
+$8.34M
4
CI icon
Cigna
CI
+$8.3M
5
MDT icon
Medtronic
MDT
+$6.47M

Sector Composition

Rank Sector Weight
1 Healthcare 85.12%
2 Consumer Staples 4.15%
3 Consumer Discretionary 3.93%
4 Technology 1.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISEE
26
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$4.06M 1.28%
250,000
-150,000
-38% -$1.63M
PLXS icon
27
Plexus
PLXS
$6.43B
$3.58M 1.13%
40,000
+26,000
+186% +$2.31M
TALK icon
28
Talkspace
TALK
$874M
$2.92M 0.92%
+800,000
New +$4.39M
DMTK
29
DELISTED
DermTech, Inc. Common Stock
DMTK
$2.73M 0.86%
85,000
-50,000
-37% -$1.76M
SPY icon
30
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$2.06M 0.65%
2,000
-1,500
-43% -$662K
NVST icon
31
Envista
NVST
$4.62B
$1.88M 0.59%
+45,000
New +$1.9M
SLGC
32
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$1.86M 0.59%
+150,000
New +$1.69M
ARKG icon
33
PUT
ARK Genomic Revolution ETF
ARKG
$1.53B
$735K 0.23%
750
-750
-50% -$62.9K
CERS icon
34
Cerus
CERS
$575M
$457K 0.14%
75,000
– –
HOLX
35
CALL
DELISTED
Hologic
HOLX
$420K 0.13%
1,000
-1,500
-60% -$112K
HSIC icon
36
CALL
Henry Schein
HSIC
$9.78B
$405K 0.13%
+1,500
New +$115K
VTRS icon
37
CALL
Viatris
VTRS
$20.8B
$250K 0.08%
+5,000
New +$70.9K
PFE icon
38
CALL
Pfizer
PFE
$143B
$156K 0.05%
1,000
-2,500
-71% -$111K
NUVA
39
PUT
DELISTED
NuVasive, Inc.
NUVA
$143K 0.05%
+231
New +$14.2K
RIGL icon
40
CALL
Rigel Pharmaceuticals
RIGL
$723M
$100K 0.03%
+500
New +$19.7K
SLGCW
41
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$69K 0.02%
+20,000
New +$61.6K
MSACW
42
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
$47K 0.01%
66,665
– –
BMRN icon
43
CALL
BioMarin Pharmaceuticals
BMRN
$11.9B
$23K 0.01%
+1,500
New +$118K
ABT icon
44
PUT
Abbott
ABT
$187B
– –
-1,000
Closed -$670K
BIO icon
45
Bio-Rad Laboratories Class A
BIO
$8.76B
– –
-1,000
Closed -$644K
BMY icon
46
CALL
Bristol-Myers Squibb
BMY
$129B
– –
-2,500
Closed -$245K
BSX icon
47
CALL
Boston Scientific
BSX
$68.4B
– –
-2,000
Closed -$258K
CI icon
48
Cigna
CI
$78.4B
– –
-35,000
Closed -$8.3M
CNC icon
49
Centene
CNC
$30.5B
– –
-35,000
Closed -$2.55M
CTVA icon
50
CALL
Corteva
CTVA
$60.5B
– –
-1,500
Closed -$158K
1
2
3

Similar funds

SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
STC
Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return
GC
Gilfoyle & Co San Francisco, California $671K AUM
DU
Delphia (USA) Toronto, Ontario, Canada $445K AUM 28.82% 1-Year Est. Return

Tamarack Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, Tamarack Advisers held 64 positions worth $317M, down 10% from $353M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Tamarack Advisers withdrew a net $25M in Q3 2021, closing 19 positions and reducing 15 holdings. Its most notable exit was UnitedHealth, an estimated $12M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 87% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, Tamarack Advisers opened a new position in Steris worth $7.35M.

  • Tamarack Advisers's largest Q3 2021 buy was Steris: 36,000 shares worth $7.35M.
  • Tamarack Advisers added most to Perrigo in Q3 2021, an estimated $8.9M increase.
  • Tamarack Advisers's biggest Q3 2021 reduction was Medtronic, cutting an estimated $6.47M.
  • Tamarack Advisers fully exited UnitedHealth in Q3 2021, selling an estimated $12M.
  • Tamarack Advisers's ten largest holdings make up 56% of its $317M portfolio in Q3 2021.
  • Tamarack Advisers opened 13 new positions and closed 19 in Q3 2021.
  • Tamarack Advisers's portfolio value fell 10% quarter-over-quarter to $317M.

Based on Tamarack Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.